San Francisco, CA (PRWEB) April 23, 2014
Philip E. Chenette, MD, director of Pacific Fertility Center’s Fertility Preservation Program, and Joseph Conaghan, PhD, PFC’s laboratory director, were recently notified that two of their abstracts on time-lapse imaging have been accepted for presentation in Munich, Germany at the 30th Annual Meeting of ESHRE, which runs from June 29 to July 2, 2014. ESHRE is the European Society of Human Reproduction and Embryology. Four international referees anonymously evaluated and selected the abstracts for oral presentation at the ESHRE meeting.
For nearly three years, Pacific Fertility Center has been at the cutting edge of research involving time-lapse technology called Eeva (Early Embryo Viability Assessment). With this technology, pictures of embryos are taken at set intervals during culture without removing them from their highly controlled environment. These images are stitched together into time-lapse videos that clearly show how each embryo has developed for up to five days in culture. It has made it possible to observe subtle, yet critical, developmental errors and to enable better choices about which embryo to transfer.
The first ESHRE abstract is entitled “Automated time-lapse analysis in adjunctive use with morphology is highly informative for diverse embryologists to select embryos with high developmental potential.” This prospective multi-center study found that combining time-lapse imaging with traditional methods of assessment helped embryologists from a variety of practices more consistently select embryos with higher developmental potential.
The second abstract is entitled "Computer-automated time-lapse analysis test results correlate to clinical pregnancy and embryo implantation: a prospective, blinded, multi-center study." With 177 patients, this study found a strong correlation between computer-generated time-lapse results and embryo implantation and pregnancy.
An internationally recognized board certified specialist in Reproductive Endocrinology and Infertility, Dr. Chenette has spent the last 20 years specializing in the treatment of complex infertility diagnoses and women over 40. He is past recipient of the American Fertility Association’s (AFA) Family Building Award. Also internationally reknown, Dr. Conaghan has more than two decades of experience in human embryology. A big advocate of elective single embryo transfer (eSET) in in vitro fertilization (IVF), he has set high standards for culturing and vitrifying embryos.
The goal of ESHRE is to promote interest in, and understanding of, reproductive biology and medicine. It does this through facilitating research and subsequent dissemination of research findings in human reproduction and embryology to the general public, scientists, clinicians, and patient associations; it also works to inform politicians and policymakers throughout Europe.
About Pacific Fertility Center
Pacific Fertility Center is an international destination for male and female fertility treatment and care. It provides an extensive array of fertility treatment options ranging from intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) to cutting-edge technology such as vitrification and genetic testing of embryos. For more information: http://www.pacificfertilitycenter.com.
Renee H. Scudder, MS
Pacific Fertility Center
55 Francisco Street, Fifth Floor
San Francisco, CA 94133